Adipotide FTPP Peptide – Targeted Apoptosis for Fat Cell Research
Adipotide (FTPP) is a peptidomimetic engineered for highly targeted metabolic research. Unlike traditional lipolytic peptides that stimulate fat breakdown (lipolysis), Adipotide is designed to induce programmed cell death (apoptosis) specifically within the blood vessels that supply white adipose tissue.
Key Research Areas:
- Selective Vascular Targeting: Adipotide FTPP contains a homing domain that identifies specific markers in the blood vessels of fat tissue. Research suggests it “starves” fat cells by cutting off their nutrient and oxygen supply without affecting the vasculature of other organs.
- Weight Loss & Adiposity: Studies involving primate models have demonstrated significant reductions in total body weight and fat mass. This makes Adipotide a primary subject for researchers looking to move beyond hormonal signaling into physical tissue reduction.
- Metabolic Syndrome & Diabetes: By reducing the volume of adipose tissue, Adipotide has been observed to improve symptoms of insulin resistance. Researchers study this peptide for its potential to reverse markers of Type 2 Diabetes by altering the metabolic milieu of the organism.
- Pro-Apoptotic Mechanism: The “FTPP” (Fat Targeting Pro-apoptotic Peptide) component triggers mitochondrial membrane disruption within the targeted vascular cells, leading to localized necrosis of the fat deposits.
Elite Peptide Supply provides high-purity Adipotide FTPP for laboratory experimentation. Our compound is synthesized to ensure the integrity of the dual-domain sequence required for accurate vascular homing and apoptotic research.
Reviews
There are no reviews yet.